Women informed of over-detection risk less likely to want mammography
the ONA take:
According to a new study published in the journal The Lancet, researchers have found that women who are better informed about the risk of over-detection and over-diagnosis associated with mammography screening are less likely to have a breast cancer screening.
Mammography screening can prevent deaths associated with breast cancer, but most women are unaware that the screening can lead to over-diagnosis and overtreatment.
For the study, researchers randomly assigned 879 women aged 48-50 years who were about to become candidates for mammography screening to receive decision support materials with or without over-detection information.
Results showed that compared with controls, more women provided with over-detection information had adequate knowledge about breast cancer screening and made an informed choice about whether to be screened, had less favorable attitudes towards breast cancer screening, and had fewer intentions to be screened for breast cancer.
The findings suggest the importance of giving women clear decision support materials so that they can make more informed decisions about whether they should receive a mammography screening.
Women who are better informed about the risk of over-detection are less likely to have a breast cancer screening.
- Osteoporosis Medication Improves Bone Health in ADT-Treated Prostate Cancer
- Inotuzumab Ozogamicin Granted FDA Approval for Acute Lymphoblastic Leukemia
- Cabazitaxel in Prostate Cancer: Reduced Dose Noninferior to Standard Dose
- Risk of Some Cancers Higher in Women With a History of Periodontal Disease
- Breast Conservation Improves Survival vs Mastectomy in Breast Cancer
- To Better Serve Patients With Cancer, Navigators Need Better Systems
- Physical Activity Improves Cognitive Function for Breast Cancer Survivors
- Risk of Lung Cancer Increases With Diets Higher in Saturated Fats
- Mechanisms Identified for Curcumin Resensitization of Cancer Cells
- Value of Type and Crossmatch Prior to Daratumumab Administration
- Affect of Daratumumab on Laboratory Blood Test Results
- Geriatric Consults Rare in Kidney Cancer Care
- Worse Survival Seen for Alternative Versus Usual Cancer Therapy
- Anorexia-Cachexia in Non-Small Cell Lung Cancer Improved With Anamorelin
- Early Recognition of Checkpoint Inhibitor-Related Pneumonitis Improves Outcomes
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|